Concepedia

Author

Diana Behrens

Max Delbrück Center

Also Known As

Behrens, Diana, D. Behrens, Diana Behrens, Diana Behrens (559737)

64

Publications

796

Citations

16

H-Index

15

Concepts

All Affiliations

Max Delbrück CenterGerman Cancer Research CenterHeidelberg UniversityCharité - Universitätsmedizin BerlinUniversity of Verona
DB

About

Diana Behrens is an author at Max Delbrück Center specializing in medicine, cell biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

149

2

Cell Biology

4

4

149

3

Pharmacology

2

2

60

4

Pathology

1

1

39

5

Cancer Cell Biology

1

1

39

Diana Behrens

×

19

Publications

716

Citations

15

H-Index

YearCitations

Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology

David Osuna de la Peña, Sara Maria David Trabulo, Estelle Collin,

Nature Communications

2021

117

The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells

Torben Redmer, Yvonne Welte, Diana Behrens,

PLoS ONE

2014

99

Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer

Natalya Beglyarova, Eugenia Banina, Yan Zhou,

Clinical Cancer Research

2016

65

The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness

Johanna Grinat, Julian Heuberger, Ramón Vidal,

Nature Communications

2020

56

Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro

Reinhard Zeisig, Renate Stahn, Katrin Wenzel,

Biochimica et Biophysica Acta (BBA) - Biomembranes

2003

50

Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo

Martin Michaelis, Iduna Fichtner, Diana Behrens,

International Journal of Oncology

2006

49

Loss of tumourigenicity of stably ERβ-transfected MCF-7 breast cancer cells

Diana Behrens, Jason H. Gill, Iduna Fichtner

Molecular and Cellular Endocrinology

2007

39

The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators

Brajesh P. Kaistha, Anja Krattenmacher, Johannes Fredebohm,

Oncotarget

2017

38

TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer

Ben Zhao, Laura Dierichs, Jiangning Gu,

Cell Death Discovery

2020

36

Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer

Giuseppina Sannino, Nicole Armbruster, Mona Bodenhöfer,

Oncotarget

2016

27

Page 1